Kalaris Therapeutics, Inc. KLRS
1.93 USD +0.06 (+3.21%)
Nov 11, 2026, 9:54 AM EST
1.80 Day range 2.38
1.78 52-week range 11.88
- YTD
- -77.13%
- 1 year
- -61.93%
- Market cap
- 44.52M
- EPS (ttm)
- -1.84
- YTD return
- -77.13%
- 1-year return
- -61.93%
- Volume
- 543
- Avg volume
- 70.88K
- Open
- 2.20
- Previous close
- 1.87
- Day's range
- 1.80 – 2.38
- 52-week range
- 1.78 – 11.88
No chart data for this range yet.
Financials — quick view
KLRS Revenue — quarterly 0
KLRS Net income — quarterly -11.52M
KLRS EPS — quarterly -0.48
News
Citizens Maintains Market Outperform on Kalaris Therapeutics, Lowers Price Target to $20 
Kalaris Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate 
Kalaris Reports Third Quarter 2026 Financial Results and Provides Business Update 
Alpha Buying: 3 Beaten-Down Biotech Stocks Backed by a Specialist Investor 
12 Health Care Stocks Moving In Thursday's Pre-Market Session 
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
Kalaris Therapeutics Q2 EPS $(0.48) Beats $(0.49) Estimate - Kalaris Therapeutics Appoints Liisa Bayko CFO
Why Is Kalaris Therapeutics Stock Gaining Friday? 
12 Health Care Stocks Moving In Friday's Intraday Session
Your note
Sign in to keep a note on KLRS — it syncs with the Stock Master app.